Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease

NCT02641054 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Parkinson Disease

Interventions

DRUG: CVXL-0107
DRUG: Placebo
DRUG: Levodopa

Sponsor

CleveXel Pharma